Patient Portal

Andrea Wang-Gillam, MD, PhD

Associate Professor, Medicine
Division of Oncology
Section of Medical Oncology

Specialty Areas

Medical Oncology
Oncology
Gastrointestinal Oncology
Pancreatic Cancer

Board Certifications

Medical Oncology
Internal Medicine

Hospital Affiliations

Barnes-Jewish Hospital

Areas of Clinical Interest

gastrointestinal cancer, pancreatic cancer

  • Maps & Directions
  • Education
  • Publication & Research

Maps & Directions

Maps & Directions

Barnes-Jewish West County Hospital
Medical Building Two

10 Barnes West Drive
Creve Coeur, MO 63141

Office Phone: 314-747-1171
Fax: 314-362-3646
Email: AWang-Gillam@WUSTL.EDU

Center for Advanced Medicine
Siteman Cancer Center

4921 Parkview Place
St. Louis, MO 63110
Phone: 314-747-7222

Suite: B
Floor: 7
Office Phone: 314-747-1171
Additional Phone: 314-362-5740
Fax: 314-362-7086
Email: AWang-Gillam@WUSTL.EDU

Education

Education

Fellowship: Hematology-Oncology, University of Arkansas for Medical Science, Little Rock, Arkansas 2007
Residency: Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas 2004
Ph.D.: School of Medicine, University of Arkansas for Medical Science, Little Rock, Arkansas 2001
Medical Degree: School of Medicine, University of Arkansas for Medical Science, Little Rock, Arkansas 2001

Publication & Research

Publication & Research

Dynamic changes during the treatment of pancreatic cancer.
Wolff RA, Wang-Gillam A, Alvarez H, Tiriac H, Engle D, Hou S, Groff AF, San Lucas A, Bernard V, Allenson K, Castillo J, Kim D, Mulu F, Huang J, Stephens B, Wistuba II, Katz M, Varadhachary G, Park Y, Hicks J, Chinnaiyan A, Scampavia L, Spicer T, Gerhardinger C, Maitra A, Tuveson D, Rinn J, Lizee G, Yee C, Levine AJ
Oncotarget. 2018 Mar 13; 9(19)14764-14790. doi: 10.18632/oncotarget.24483.

PMID:
    29599906
    [PubMed]
Related citations


Utility of Endoscopic Ultrasound in Evaluating Local Recurrence After Surgery for Pancreatic Cancer.
Lang GD, Mullady DK, Early DS, Hollander T, Edmundowicz SA, Murad FM, Strasberg SM, Fields RC, Hawkins WG, Doyle MB, Chapman WC, Wang-Gillam A, Kushnir VM
Clin Gastroenterol Hepatol. 2018 Mar 2; pii: S1542-3565(18)30219-2. doi: 10.1016/j.cgh.2018.02.031.

PMID:
    29505906
    [PubMed - as supplied by publisher]
Related citations


Tumor-Stroma IL1β-IRAK4 Feedforward Circuitry Drives Tumor Fibrosis, Chemoresistance, and Poor Prognosis in Pancreatic Cancer.
Zhang D, Li L, Jiang H, Li Q, Wang-Gillam A, Yu J, Head R, Liu J, Ruzinova MB, Lim KH
Cancer Res. 2018 Apr 1; 78(7)1700-1712. doi: 10.1158/0008-5472.CAN-17-1366.

PMID:
    29363544
    [PubMed - in process]
Related citations


Pacritinib to inhibit JAK/STAT signaling in refractory metastatic colon and rectal cancer.
Regenbogen T, Chen L, Trinkaus K, Wang-Gillam A, Tan BR, Amin M, Pedersen KS, Park H, Suresh R, Lim KH, Ratchford E, Brown A, Lockhart AC
J Gastrointest Oncol. 2017 Dec; 8(6)985-989. doi: 10.21037/jgo.2017.08.16.

PMID:
    29299358
    [PubMed]
Related citations


First-in-Class ERK1/2 Inhibitor Ulixertinib (BVD-523) in Patients with MAPK Mutant Advanced Solid Tumors: Results of a Phase I Dose-Escalation and Expansion Study.
Sullivan RJ, Infante JR, Janku F, Wong DJL, Sosman JA, Keedy V, Patel MR, Shapiro GI, Mier JW, Tolcher AW, Wang-Gillam A, Sznol M, Flaherty K, Buchbinder E, Carvajal RD, Varghese AM, Lacouture ME, Ribas A, Patel SP, DeCrescenzo GA, Emery CM, Groover AL, Saha S, Varterasian M, Welsch DJ, Hyman DM, Li BT
Cancer Discov. 2018 Feb; 8(2)184-195. doi: 10.1158/2159-8290.CD-17-1119.

PMID:
    29247021
    [PubMed - in process]
Related citations


HALO 202: Randomized Phase II Study of PEGPH20 Plus Nab-Paclitaxel/Gemcitabine Versus Nab-Paclitaxel/Gemcitabine in Patients With Untreated, Metastatic Pancreatic Ductal Adenocarcinoma.
Hingorani SR, Zheng L, Bullock AJ, Seery TE, Harris WP, Sigal DS, Braiteh F, Ritch PS, Zalupski MM, Bahary N, Oberstein PE, Wang-Gillam A, Wu W, Chondros D, Jiang P, Khelifa S, Pu J, Aldrich C, Hendifar AE
J Clin Oncol. 2018 Feb 1; 36(4)359-366. doi: 10.1200/JCO.2017.74.9564.

PMID:
    29232172
    [PubMed - in process]
Related citations


Trends in Neoadjuvant Approaches in Pancreatic Cancer.
Du L, Wang-Gillam A
J Natl Compr Canc Netw. 2017 Aug; 15(8)1070-1077. doi: 10.6004/jnccn.2017.0134.

PMID:
    28784867
    [PubMed - indexed for MEDLINE]
Related citations


Promising therapeutics of gastrointestinal cancers in clinical trials.
Du L, Che Z, Wang-Gillam A
J Gastrointest Oncol. 2017 Jun; 8(3)524-533. doi: 10.21037/jgo.2017.01.08.

PMID:
    28736639
    [PubMed]
Related citations


Entering the molecular era of gastrointestinal oncology: current updates and challenges.
Wang-Gillam A, Lim KH
J Gastrointest Oncol. 2017 Jun; 8(3)377-378. doi: 10.21037/jgo.2017.05.02.

PMID:
    28736625
    [PubMed]
Related citations


A clinically feasible multiplex proteomic immunoassay as a novel functional diagnostic for pancreatic ductal adenocarcinoma.
Lim KH, Langley E, Gao F, Luo J, Li L, Meyer G, Kim P, Singh S, Kushnir VM, Early DS, Mullady DK, Edmundowicz SA, Wani S, Murad FM, Cao D, Azar RR, Wang-Gillam A
Oncotarget. 2017 Apr 11; 8(15)24250-24261. doi: 10.18632/oncotarget.15653.

PMID:
    28445954
    [PubMed - indexed for MEDLINE]
Related citations


Quality-adjusted survival with combination nal-IRI+5-FU/LV vs 5-FU/LV alone in metastatic pancreatic cancer patients previously treated with gemcitabine-based therapy: a Q-TWiST analysis.
Pelzer U, Blanc JF, Melisi D, Cubillo A, Von Hoff DD, Wang-Gillam A, Chen LT, Siveke JT, Wan Y, Solem CT, Botteman MF, Yang Y, de Jong FA, Hubner RA
Br J Cancer. 2017 May 9; 116(10)1247-1253. doi: 10.1038/bjc.2017.67.

PMID:
    28350787
    [PubMed - indexed for MEDLINE]
Related citations


Effect of Selumetinib and MK-2206 vs Oxaliplatin and Fluorouracil in Patients With Metastatic Pancreatic Cancer After Prior Therapy: SWOG S1115 Study Randomized Clinical Trial.
Chung V, McDonough S, Philip PA, Cardin D, Wang-Gillam A, Hui L, Tejani MA, Seery TE, Dy IA, Al Baghdadi T, Hendifar AE, Doyle LA, Lowy AM, Guthrie KA, Blanke CD, Hochster HS
JAMA Oncol. 2017 Apr 1; 3(4)516-522. doi: 10.1001/jamaoncol.2016.5383.

PMID:
    27978579
    [PubMed - indexed for MEDLINE]
Related citations


Nanoliposomal Irinotecan in the Clinical Practice Guideline for Metastatic Pancreatic Cancer: Applicability to Clinical Situations.
Wang-Gillam A, Von Hoff D, Siveke J, Hubner R, Belanger B, Pipas JM, Chen LT
J Clin Oncol. 2017 Feb 20; 35(6)689-690. doi: 10.1200/JCO.2016.70.1607.

PMID:
    27918719
    [PubMed - in process]
Related citations


Utility of a multidisciplinary tumor board in the management of pancreatic and upper gastrointestinal diseases: an observational study.
Brauer DG, Strand MS, Sanford DE, Kushnir VM, Lim KH, Mullady DK, Tan BR Jr, Wang-Gillam A, Morton AE, Ruzinova MB, Parikh PJ, Narra VR, Fowler KJ, Doyle MB, Chapman WC, Strasberg SS, Hawkins WG, Fields RC
HPB (Oxford). 2017 Feb; 19(2)133-139. doi: 10.1016/j.hpb.2016.11.002.

PMID:
    27916436
    [PubMed - indexed for MEDLINE]
Related citations


PET of Poly (ADP-Ribose) Polymerase Activity in Cancer: Preclinical Assessment and First In-Human Studies.
Michel LS, Dyroff S, Brooks FJ, Spayd KJ, Lim S, Engle JT, Phillips S, Tan B, Wang-Gillam A, Bognar C, Chu W, Zhou D, Mach RH, Laforest R, Chen DL
Radiology. 2017 Feb; 282(2)453-463. doi: 10.1148/radiol.2016161929.

PMID:
    27841728
    [PubMed - indexed for MEDLINE]
Related citations


Chemotherapy-associated Posterior Reversible Encephalopathy Syndrome: A Case Report and Review of the Literature.
How J, Blattner M, Fowler S, Wang-Gillam A, Schindler SE
Neurologist. 2016 Nov; 21(6)112-117.

PMID:
    27801773
    [PubMed - indexed for MEDLINE]
Related citations


Constitutive IRAK4 Activation Underlies Poor Prognosis and Chemoresistance in Pancreatic Ductal Adenocarcinoma.
Zhang D, Li L, Jiang H, Knolhoff BL, Lockhart AC, Wang-Gillam A, DeNardo DG, Ruzinova MB, Lim KH
Clin Cancer Res. 2017 Apr 1; 23(7)1748-1759. doi: 10.1158/1078-0432.CCR-16-1121.

PMID:
    27702822
    [PubMed - indexed for MEDLINE]
Related citations


Racial Disparities in the Outcomes of Patients With Stage IV Pancreatic Adenocarcinoma Are Mediated by Chemotherapy Utilization.
Atkins JJ, Fiala MA, Wang-Gillam A, Wildes TM
Pancreas. 2016 Aug; 45(7)e33-4. doi: 10.1097/MPA.0000000000000618.

PMID:
    27400157
    [PubMed - indexed for MEDLINE]
Related citations


Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy.
Jiang H, Hegde S, Knolhoff BL, Zhu Y, Herndon JM, Meyer MA, Nywening TM, Hawkins WG, Shapiro IM, Weaver DT, Pachter JA, Wang-Gillam A, DeNardo DG
Nat Med. 2016 Aug; 22(8)851-60. doi: 10.1038/nm.4123.

PMID:
    27376576
    [PubMed - indexed for MEDLINE]
Related citations


Nanoliposomal irinotecan in metastatic pancreatic cancer - Authors' reply.
Chen LT, Wang-Gillam A, Von Hoff DD, Bayever E, Belanger B
Lancet. 2016 May 14; 387(10032)1997. doi: 10.1016/S0140-6736(16)30365-8.

PMID:
    27203770
    [PubMed - indexed for MEDLINE]
Related citations